Literature DB >> 7713497

Structure and expression of the human lysyl hydroxylase gene (PLOD): introns 9 and 16 contain Alu sequences at the sites of recombination in Ehlers-Danlos syndrome type VI patients.

J Heikkinen1, T Hautala, K I Kivirikko, R Myllylä.   

Abstract

Lysyl hydroxylase (EC 1.14.11.4) catalyzes the formation of hydroxylysine in collagens by the hydroxylation of lysine residues in peptide linkages. This enzyme activity is known to be reduced in patients with the type VI variant of the Ehlers-Danlos syndrome, and the first mutations in the lysyl hydroxylase gene (PLOD) have recently been identified. We have now isolated genomic clones for human lysyl hydroxylase and determined the complete structure of the gene, which contains 19 exons and a 5' flanking region with characteristics shared by housekeeping genes. The constitutive expression of the gene in different tissues further suggests that lysyl hydroxylase has an essential function. We have sequenced the introns of the gene in the region where many mutations and rearrangements analyzed to date are concentrated. Intron 9 and intron 16 show extensive homology resulting from the many Alu sequences found in these introns. Intron 9 contains five and intron 16 eight Alu sequences. The high homology and many short identical or complementary sequences in these introns generate many potential recombination sites with the gene. The delineation of the structure of the lysyl hydroxylase gene contributes significantly to our understanding of the rearrangements in the genome of Ehlers-Danlos type VI patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7713497     DOI: 10.1006/geno.1994.1654

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

Review 1.  Ehlers-Danlos syndrome has varied molecular mechanisms.

Authors:  F M Pope; N P Burrows
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

2.  Genetic linkage analysis of 14 candidate gene loci in a family with autosomal dominant osteoarthritis without dysplasia.

Authors:  I Meulenbelt; C Bijkerk; F C Breedveld; P E Slagboom
Journal:  J Med Genet       Date:  1997-12       Impact factor: 6.318

3.  PLOD1 acts as a tumor promoter in glioma via activation of the HSF1 signaling pathway.

Authors:  Bo Yuan; Yimin Xu; Shaoqin Zheng
Journal:  Mol Cell Biochem       Date:  2021-11-29       Impact factor: 3.396

4.  PLOD Family: A Novel Biomarker for Prognosis and Personalized Treatment in Soft Tissue Sarcoma.

Authors:  Siming Gong; Nikolas Schopow; Yingjuan Duan; Changwu Wu; Sonja Kallendrusch; Georg Osterhoff
Journal:  Genes (Basel)       Date:  2022-04-28       Impact factor: 4.141

5.  Cloning and characterization of a third human lysyl hydroxylase isoform.

Authors:  K Passoja; K Rautavuoma; L Ala-Kokko; T Kosonen; K I Kivirikko
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

6.  Clinical Prognostic Value of the PLOD Gene Family in Lung Adenocarcinoma.

Authors:  Yiming Meng; Jing Sun; Guirong Zhang; Tao Yu; Haozhe Piao
Journal:  Front Mol Biosci       Date:  2022-02-21

7.  Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase Family: Novel Prognostic Biomarkers and Tumor Microenvironment Regulators for Lower-Grade Glioma.

Authors:  Siming Gong; Changwu Wu; Franziska Köhler; Jürgen Meixensberger; Nikolas Schopow; Sonja Kallendrusch
Journal:  Front Cell Neurosci       Date:  2022-02-18       Impact factor: 5.505

8.  A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3).

Authors:  Siming Gong; Yingjuan Duan; Changwu Wu; Georg Osterhoff; Nikolas Schopow; Sonja Kallendrusch
Journal:  Int J Mol Sci       Date:  2021-09-14       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.